{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:52Z","timestamp":1790845552173,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["KSCX2-EW-J27"],"award-info":[{"award-number":["KSCX2-EW-J27"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bureau of Science and Technology of Guangzhou Municipality","award":["2011J2200002"],"award-info":[{"award-number":["2011J2200002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bmcl.2015.02.014","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T12:32:53Z","timestamp":1424089973000},"page":"1538-1540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ritonavir-boosted indinavir but not lopinavir inhibits erythrocytic stage Plasmodium knowlesi malaria in rhesus macaques"],"prefix":"10.1016","volume":"25","author":[{"given":"Li","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2015.02.014_b0005","unstructured":"WHO. HIV\/AIDS Fact sheet World Health Organization, Geneva, Switzerland http:\/\/wwwwhoint\/mediacentre\/factsheets\/fs360\/en\/ November 2014."},{"key":"10.1016\/j.bmcl.2015.02.014_b0010","unstructured":"WHO. Malaria Fact sheet. World Health Organization, Geneva, Switzerland http:\/\/wwwwhoint\/mediacentre\/factsheets\/fs094\/en\/ December 2014."},{"key":"10.1016\/j.bmcl.2015.02.014_b0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1473-3099(11)70031-7","volume":"11","author":"Flateau","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bmcl.2015.02.014_b0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.50.2.639-648.2006","volume":"50","author":"Andrews","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2015.02.014_b0025","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.49.7.2983-2985.2005","volume":"49","author":"Parikh","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2015.02.014_b0030","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1086\/425584","volume":"190","author":"Skinner-Adams","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bmcl.2015.02.014_b0035","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1128\/AAC.01329-07","volume":"52","author":"He","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2015.02.014_b0040","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.00169-08","volume":"52","author":"Lek-Uthai","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2015.02.014_b0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/594369","volume":"199","author":"Hobbs","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bmcl.2015.02.014_b0050","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMoa1200501","volume":"367","author":"Achan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bmcl.2015.02.014_b0055","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.05322-11","volume":"56","author":"Porter","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2015.02.014_b0060","doi-asserted-by":"crossref","first-page":"e34399","DOI":"10.1371\/journal.pone.0034399","volume":"7","author":"Skinner-Adams","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2015.02.014_b0065","first-page":"914","volume":"10","author":"Waters","year":"1993","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.bmcl.2015.02.014_b0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/524888","volume":"46","author":"Cox-Singh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bmcl.2015.02.014_b0075","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3201\/eid1012.040293","volume":"10","author":"Jongwutiwes","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bmcl.2015.02.014_b0080","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.00085-11","volume":"55","author":"Li","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2015.02.014_b0085","unstructured":"FDA. Guidance for Industry. Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers.volunteers, http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm078932.pdf. U.S. Food and Drug Administration: Washington, DC, 2005, p 7."},{"key":"10.1016\/j.bmcl.2015.02.014_b0090","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/jac\/dkr596","volume":"67","author":"Byakika-Kibwika","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bmcl.2015.02.014_b0095","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2875-8-S1-S4","volume":"8","author":"Djimde","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.bmcl.2015.02.014_b0100","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. http:\/\/www.aidsinfo.nih.gov\/guidelines\/. 2011."},{"key":"10.1016\/j.bmcl.2015.02.014_b0105","unstructured":"Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Childrens. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. http:\/\/www.aidsinfo.nih.gov\/guidelines\/ 2012."},{"key":"10.1016\/j.bmcl.2015.02.014_b0110","unstructured":"World Health Organization. Geneva: WHO. Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach-2010 Revision. 2010."},{"key":"10.1016\/j.bmcl.2015.02.014_b0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1468-1293.2009.00759.x","volume":"10","author":"Welch","year":"2009","journal-title":"HIV Med."},{"key":"10.1016\/j.bmcl.2015.02.014_b0120","unstructured":"Panel on Antiretroviral Therapy and Medical Management of HIV Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Updated August 16, [Accessed January 01, 2011] Available at http:\/\/aidsinfo.nih.gov\/contentfiles\/PediatricGuidelines.pdf. 2010."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X15001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X15001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:59:09Z","timestamp":1760770749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X15001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0960894X15001213"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2015.02.014","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ritonavir-boosted indinavir but not lopinavir inhibits erythrocytic stage Plasmodium knowlesi malaria in rhesus macaques","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2015.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}